ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 157995 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 157995; 2) Community: the network communities that were significantly associated with the response to NSC 157995; 3) Molecule: the relationships between components within communities and NSC 157995; 4) MDR: the compounds that were significantly associated with the NSC 157995.

NSC Compound Enrichment Correlation
NSC 640499 2,2':6',2"-Terpyridine, 4'-[4-(2-hydroxyethoxy)phenyl]- 0.0100995289754787 -0.074502104
NSC 662123 Null 0.0100995289754787 0.059140297
NSC 671174 Null 0.0100995289754787 -0.13774871
NSC 679795 Null 0.0100995289754787 0.38036229
NSC 694000 2-Butenedioic acid, (E)-, 2-[3-[[[[2-(acetyloxy)ethoxy] methyl]-3H-1,2,3-triazol-4-yl]methyl]- 1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-,diethyl ester 0.0100995289754787 -0.02439572
NSC 736606 Null 0.0100995289754787 -0.014365605
NSC 746687 (2E)-3-(2-phenyl-1H-indol-3-yl)-2-(phenylsulfonyl)acrylonitrile 0.0100995289754787 -0.057383949
NSC 295501 Camptothecin Derivative 0.0102077332082016 0.39272531
NSC 308847 Amonafide 0.0102077332082016 -0.060308403
NSC 45029 1,4-Naphthoquinone, 2-chloro-3-furfurylamino- 0.0102077332082016 0.044563159
Total:54  Current:11    [First] [Prev] [Next] [Last]